Properties
What is it?
International Nonproprietary Name - fluticasone propionate, azelastine Clinical-pharmacological group: Glucocorticoids → Glucocorticoid agents for topical use → ENT preparations Composition Each spray dose contains: Active substance: Azelastine hydrochloride 137 mcg, Fluticasone propionate 50 mcg. Excipients: Microcrystalline cellulose, Sodium carboxymethylcellulose, Glycerin, Anhydrous glucose, Phenylethyl alcohol, Disodium edetate, Polysorbate 80, Benzalkonium chloride, Hydrochloric acid and/or Sodium hydroxide, Purified water. Pharmacotherapeutic group Decongestants and other nasal preparations for topical use. Corticosteroids. Fluticasone, combinations. Indications for use Used to reduce symptoms of seasonal or perennial allergic rhinitis when treatment with an intranasal antihistamine or glucocorticoid is insufficient. Method of use and dosage The preparation Flutell Plus is intended for nasal use only. Before use, it is necessary to shake the bottle carefully for 5 seconds up and down, in a tilted position, after which the cap should be removed. Before the first use of Flutell Plus, it is necessary to prepare it for use by pressing and releasing the pump 6 times. If the preparation has not been used for 7 days, it should be re-prepared for use by pressing and releasing the pump once. After clearing the nose, spray the suspension into each nostril, tilting the head downwards. After use, dry the tip of the sprayer and close the cap. For complete therapeutic effect, regular use of the preparation is necessary. Avoid contact with eyes. The preparation can be used for a long time. The duration of treatment should correspond to the period of allergen exposure. Adults and adolescents (12 years and older): one spray in each nostril 2 times a day (morning and evening). Children under 12 years of age: The use of Flutell Plus is not recommended in children under 12 years of age, as its safety and efficacy in this age group have not been established. Elderly patients Dose adjustment is not required in this age group. Renal and hepatic impairment No data are available in patients with renal and hepatic impairment. Contraindications Hypersensitivity to the active substances or any of the excipients.